Published in Respir Res on June 13, 2007
Elevated levels of NO are localized to distal airways in asthma. Free Radic Biol Med (2011) 0.82
Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses. PLoS One (2013) 0.80
Eosinophil-associated lung diseases. A cry for surfactant proteins A and D help? Am J Respir Cell Mol Biol (2014) 0.79
Surfactant protein D facilitates Cryptococcus neoformans infection. Infect Immun (2012) 0.78
Role of mannose-binding lectin deficiency in HIV-1 and schistosoma infections in a rural adult population in Zimbabwe. PLoS One (2015) 0.76
Surfactant protein D inhibits HIV-1 infection of target cells via interference with gp120-CD4 interaction and modulates pro-inflammatory cytokine production. PLoS One (2014) 0.75
Integrating Lung Physiology, Immunology, and Tuberculosis. Trends Microbiol (2017) 0.75
Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med (1995) 3.80
A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med (1989) 2.95
Collections and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol (2001) 2.90
MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet (2002) 2.87
Localization of lung surfactant protein D on mucosal surfaces in human tissues. J Immunol (2000) 1.95
Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet (1997) 1.92
Surfactant content in children with inflammatory lung disease. Crit Care Med (1996) 1.76
Collectins and pulmonary host defense. Am J Respir Cell Mol Biol (1998) 1.57
Lymphocytic alveolitis, bronchoalveolar lavage viral load, and outcome in human immunodeficiency virus infection. Am J Respir Crit Care Med (1999) 1.42
Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumonia. Clin Immunol (2003) 1.12
Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections. Chest (2004) 1.12
Respiratory innate immune proteins differentially modulate the neutrophil respiratory burst response to influenza A virus. Am J Physiol Lung Cell Mol Physiol (2005) 1.08
Pulmonary surfactant proteins A and D directly suppress CD3+/CD4+ cell function: evidence for two shared mechanisms. J Immunol (2002) 1.05
Mannose-binding lectin enhances phagocytosis and killing of Neisseria meningitidis by human macrophages. J Leukoc Biol (2004) 1.03
Surfactant protein D in the female genital tract. Mol Hum Reprod (2004) 0.99
Surfactant protein D binds to human immunodeficiency virus (HIV) envelope protein gp120 and inhibits HIV replication. J Gen Virol (2005) 0.93
The role of mannose-binding protein in host defence. Biochem Soc Trans (1993) 0.93
Inhibition of DC-SIGN-mediated trans infection of T cells by mannose-binding lectin. Immunology (2003) 0.92
The level of the serum opsonin, mannan-binding protein in HIV-1 antibody-positive patients. Clin Exp Immunol (1995) 0.90
Opsonic phagocytosis of Streptococcus pneumoniae by alveolar macrophages is not impaired in human immunodeficiency virus-infected Malawian adults. J Infect Dis (2001) 0.89
Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome. Crit Care Med (2006) 0.89
Mannose-binding lectin does not act as an acute-phase reactant in adults with community-acquired pneumococcal pneumonia. Clin Exp Immunol (2006) 0.88
Circulating levels of mannose binding protein in human immunodeficiency virus infection. J Infect (1995) 0.87
Mannose-binding lectin and meningococcal disease. Lancet (1999) 0.84
Mannose-binding protein in HIV-seropositive patients does not contribute to disease progression or bacterial infections. Int J STD AIDS (1998) 0.81
The role of the collectin system in pulmonary defence. Paediatr Respir Rev (2001) 0.80
IFITM3 restricts the morbidity and mortality associated with influenza. Nature (2012) 4.66
Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med (2007) 4.56
The uptake and accuracy of oral kits for HIV self-testing in high HIV prevalence setting: a cross-sectional feasibility study in Blantyre, Malawi. PLoS Med (2011) 3.25
Indoor air pollution from biomass fuel smoke is a major health concern in the developing world. Trans R Soc Trop Med Hyg (2008) 3.02
Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS (2002) 2.83
Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis (2002) 2.54
Population-level reduction in adult mortality after extension of free anti-retroviral therapy provision into rural areas in northern Malawi. PLoS One (2010) 2.36
Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial. Lancet Infect Dis (2011) 2.32
A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults. N Engl J Med (2010) 2.30
HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa. AIDS (2004) 2.12
Diagnosis of childhood tuberculosis and host RNA expression in Africa. N Engl J Med (2014) 2.12
Underestimation of HIV prevalence in surveys when some people already know their status, and ways to reduce the bias. AIDS (2013) 2.06
Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study. PLoS Med (2013) 1.91
Profile: the Karonga Health and Demographic Surveillance System. Int J Epidemiol (2012) 1.85
Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults. Am J Respir Crit Care Med (2013) 1.84
High accuracy of home-based community rapid HIV testing in rural Malawi. J Acquir Immune Defic Syndr (2010) 1.73
Assessing the safety of stem cell therapeutics. Cell Stem Cell (2011) 1.60
Airborne endotoxin concentrations in homes burning biomass fuel. Environ Health Perspect (2010) 1.50
Measuring concurrency: an empirical study of different methods in a large population-based survey and evaluation of the UNAIDS guidelines. AIDS (2012) 1.40
Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi. PLoS One (2011) 1.39
Age at menarche, schooling, and sexual debut in northern Malawi. PLoS One (2010) 1.39
Combining qualitative and quantitative evidence to determine factors leading to late presentation for antiretroviral therapy in Malawi. PLoS One (2011) 1.38
Adult mortality and probable cause of death in rural northern Malawi in the era of HIV treatment. Trop Med Int Health (2012) 1.38
The effect of antiretroviral therapy provision on all-cause, AIDS and non-AIDS mortality at the population level--a comparative analysis of data from four settings in Southern and East Africa. Trop Med Int Health (2012) 1.38
Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis (2012) 1.38
Molecular detection of mixed infections of Mycobacterium tuberculosis strains in sputum samples from patients in Karonga District, Malawi. J Clin Microbiol (2010) 1.33
The burden of COPD in Africa: a literature review and prospective survey of the availability of spirometry for COPD diagnosis in Africa. Trop Med Int Health (2009) 1.31
Invasive group B streptococcal infection in infants, Malawi. Emerg Infect Dis (2007) 1.31
Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1-infected adults attending an HIV/AIDS clinic in Uganda. J Acquir Immune Defic Syndr (2006) 1.29
Childhood malaria in a region of unstable transmission and high human immunodeficiency virus prevalence. Pediatr Infect Dis J (2003) 1.28
Interactions between HIV and malaria in non-pregnant adults: evidence and implications. AIDS (2006) 1.20
Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage. PLoS Pathog (2012) 1.18
Bronchoalveolar CD4+ T cell responses to respiratory antigens are impaired in HIV-infected adults. Thorax (2011) 1.17
Comparison between nasopharyngeal swab and nasal wash, using culture and PCR, in the detection of potential respiratory pathogens. BMC Res Notes (2011) 1.12
Identification and characterization of ceftriaxone resistance and extended-spectrum beta-lactamases in Malawian bacteraemic Enterobacteriaceae. J Antimicrob Chemother (2006) 1.11
Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury. Hepatology (2013) 1.10
Assessing the validity of sexual behaviour reports in a whole population survey in rural Malawi. PLoS One (2011) 1.10
Conjugate pneumococcal vaccine in HIV-infected Ugandans and the effect of past receipt of polysaccharide vaccine. J Infect Dis (2005) 1.10
The impact of HIV and ART on recurrent tuberculosis in a sub-Saharan setting. AIDS (2012) 1.10
Experimental human pneumococcal carriage. J Vis Exp (2013) 1.09
Cytokine responses and progression to active tuberculosis in HIV-1-infected Ugandans: a prospective study. Trans R Soc Trop Med Hyg (2004) 1.09
Group B Streptococcus and HIV infection in pregnant women, Malawi, 2008-2010. Emerg Infect Dis (2011) 1.08
Fertility intentions and use of contraception among monogamous couples in northern Malawi in the context of HIV testing: a cross-sectional analysis. PLoS One (2012) 1.04
23-Valent pneumococcal polysaccharide vaccine in HIV-infected Ugandan adults: 6-year follow-up of a clinical trial cohort. AIDS (2004) 1.03
Genetic characterisation of Malawian pneumococci prior to the roll-out of the PCV13 vaccine using a high-throughput whole genome sequencing approach. PLoS One (2012) 1.03
Monitoring the impact of decentralised chronic care services on patient travel time in rural Africa--methods and results in Northern Malawi. Int J Health Geogr (2012) 1.02
Bacterial meningitis in Malawian adults, adolescents, and children during the era of antiretroviral scale-up and Haemophilus influenzae type b vaccination, 2000-2012. Clin Infect Dis (2014) 1.02
T regulatory cells control susceptibility to invasive pneumococcal pneumonia in mice. PLoS Pathog (2012) 1.01
Primary macrophages from HIV-infected adults show dysregulated cytokine responses to Salmonella, but normal internalization and killing. AIDS (2007) 1.01
Experimental human pneumococcal carriage models for vaccine research. Trends Microbiol (2011) 1.01
Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung. PLoS Pathog (2013) 1.01
Impaired CD4 T cell memory response to Streptococcus pneumoniae precedes CD4 T cell depletion in HIV-infected Malawian adults. PLoS One (2011) 1.00
High mortality amongst adolescents and adults with bacterial meningitis in sub-Saharan Africa: an analysis of 715 cases from Malawi. PLoS One (2013) 0.99
Domestic smoke exposure is associated with alveolar macrophage particulate load. Trop Med Int Health (2009) 0.99
Lung fluid immunoglobulin from HIV-infected subjects has impaired opsonic function against pneumococci. Clin Infect Dis (2007) 0.98
A cross-sectional study of household biomass fuel use among a periurban population in Malawi. Ann Am Thorac Soc (2014) 0.97
Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children. Clin Vaccine Immunol (2013) 0.96
Changes in Mycobacterium tuberculosis genotype families over 20 years in a population-based study in Northern Malawi. PLoS One (2010) 0.96
Control of (multi)drug resistance and tuberculosis incidence over 23 years in the context of a well-supported tuberculosis programme in rural Malawi. PLoS One (2013) 0.96
Blood culture collection technique and pneumococcal surveillance in Malawi during the four year period 2003-2006: an observational study. BMC Infect Dis (2008) 0.95
HIV and the risk of tuberculosis due to recent transmission over 12 years in Karonga District, Malawi. Trans R Soc Trop Med Hyg (2009) 0.95
Characterizing the emergence and persistence of drug resistant mutations in HIV-1 subtype C infections using 454 ultra deep pyrosequencing. BMC Infect Dis (2013) 0.95
Potential role for mucosally active vaccines against pneumococcal pneumonia. Trends Microbiol (2009) 0.93
Human microbial challenge: the ultimate animal model. Lancet Infect Dis (2012) 0.93
Pneumococcal conjugate vaccine is immunogenic in lung fluid of HIV-infected and immunocompetent adults. J Allergy Clin Immunol (2007) 0.92
Eosinophilia and progression to active tuberculosis in HIV-1-infected Ugandans. Trans R Soc Trop Med Hyg (2004) 0.91
Drug resistance mutations in drug-naive HIV type 1 subtype C-infected individuals from rural Malawi. AIDS Res Hum Retroviruses (2010) 0.91
P4-mediated antibody therapy in an acute model of invasive pneumococcal disease. J Infect Dis (2012) 0.90
Household air pollution: a call for studies into biomarkers of exposure and predictors of respiratory disease. Am J Physiol Lung Cell Mol Physiol (2013) 0.89
Density and duration of pneumococcal carriage is maintained by transforming growth factor β1 and T regulatory cells. Am J Respir Crit Care Med (2014) 0.89
HIV-1 protease inhibitors for treatment of visceral leishmaniasis in HIV-co-infected individuals. Lancet Infect Dis (2013) 0.89
Proteomic analysis of cerebrospinal fluid in pneumococcal meningitis reveals potential biomarkers associated with survival. J Infect Dis (2010) 0.89
Cryptococcus neoformans-reactive and total immunoglobulin profiles of human immunodeficiency virus-infected and uninfected Ugandans. Clin Diagn Lab Immunol (2005) 0.88
Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis. J Pharmacol Exp Ther (2012) 0.87
Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses. Vaccine (2008) 0.87
Reduced interleukin-8 response to Streptococcus pneumoniae by alveolar macrophages from adults with HIV/AIDS. AIDS (2005) 0.85
A polymorphism that reduces RANTES expression is associated with protection from death in HIV-seropositive Ugandans with advanced disease. J Infect Dis (2006) 0.84
Nanocarriers targeting dendritic cells for pulmonary vaccine delivery. Pharm Res (2012) 0.84
A CD45 polymorphism associated with abnormal splicing is absent in African populations. Immunogenetics (2002) 0.82
Household air pollution causes dose-dependent inflammation and altered phagocytosis in human macrophages. Am J Respir Cell Mol Biol (2015) 0.82
Maternal HIV status associated with under-five mortality in rural Northern Malawi: a prospective cohort study. J Acquir Immune Defic Syndr (2015) 0.82
Detection limits in pneumococcal carriage. Pediatr Infect Dis J (2013) 0.81
In silico analysis of HLA associations with drug-induced liver injury: use of a HLA-genotyped DNA archive from healthy volunteers. Genome Med (2012) 0.81
Characterising B cell numbers and memory B cells in HIV infected and uninfected Malawian adults. BMC Infect Dis (2010) 0.80
HIV in Africa (Communication arising): chemokine-receptor genes and AIDS risk. Nature (2002) 0.80
Persistence of pneumolysin in the cerebrospinal fluid of patients with pneumococcal meningitis is associated with mortality. Clin Infect Dis (2012) 0.80
Naturally-acquired influenza-specific CD4+ T-cell proliferative responses are impaired in HIV-infected African adults. PLoS One (2012) 0.79
Negative feedback on IL-23 exerted by IL-17A during pulmonary inflammation. Innate Immun (2013) 0.79
rhIL-12 as adjuvant augments lung cell cytokine responses to pneumococcal whole cell antigen. Immunobiology (2011) 0.79
Pneumococcal Acquisition Among Infants Exposed to HIV in Rural Malawi: A Longitudinal Household Study. Am J Epidemiol (2015) 0.78
Effect of recurrent invasive pneumococcal disease on serum anti-pneumolysin IgG titres in HIV infected adults. Vaccine (2009) 0.78
The alveolar microenvironment of patients infected with human immunodeficiency virus does not modify alveolar macrophage interactions with Streptococcus pneumoniae. Clin Vaccine Immunol (2013) 0.78